Brief: Pulse Biosciences Announces Presentation Of Late-Breaking Data From The NPULSE Cardiac Surgical System
10/10/2025 15:44
Oct 10 (Reuters) - Pulse Biosciences Inc PLSE.O: PULSE BIOSCIENCES ANNOUNCES PRESENTATION OF LATE-BREAKING DATA FROM THE NPULSE™ CARDIAC SURGICAL SYSTEM FIRST-IN-HUMAN FEASIBILITY STUDY AT THE 39TH EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY ANNUAL MEETING PULSE BIOSCIENCES INC - NO MAJOR ADVERSE EVENTS REPORTED IN NPULSE CARDIAC SURGICAL SYSTEM FEASIBILITY STUDY Source text: ID:nBw3l7yRga Further company coverage: PLSE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants